OPTIC NEURITIS TREATMENT TRIAL COOPERATING CLINIC

这是一份成为合作诊所之一的申请 视神经炎治疗试验。ONTT包括 基本上有两个研究部分；(1)临床试验 口服泼尼松与静脉注射甲基强的松龙的疗效比较 减少视神经病变患者的残余视神经损伤 视神经炎；(2)视神经炎自然病史的研究。 在这份提案中，我们记录了我们招募患者的潜力。 我们的眼科医生和神经学家小组观察了130名患者 患有视神经炎，26名患者符合列出的研究 在12个月内符合条件。此外，我们还提供数据 从我们转诊区域的一位神经眼科医生那里，愿意 转介患者参加这项研究，他们总共看过8名患者 视神经炎在12个月内达到研究标准 句号。

This is an application to become one of the cooperating clinics in the optic neuritis treatment trial. The ONTT consist of essentially two research components; (1) a clinical trial of the efficacy of oral prednisone and intravenous methylprednisolone in reducing residual optic nerve damage in patients with optic neuritis; and (2) a study of the natural history of optic neuritis. In this proposal we document our patient recruitment potential. Our group of ophthalmologists and neurologists saw 130 patients with optic neuritis, with 26 patients meeting the listed study criteria within a 12 month period. In addition we provide data from one neuro-ophthalmologist in our referral area, willing to refer patients for the study, who has seen a total eight patients with optic neuritis meeting the study criteria within a 12 month period.